4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Gujarat Themis Biosyn Limited (GUJTHEM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India. Its market capitalization is roughly ₹48 billion. In the fiscal year ended 2026-03-31, GUJTHEM reported ₹1.7B in revenue and ₹467M in net income.
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals, medicinal chemicals, and active pharmaceutical ingredients in India and internationally. The company offers bulk drugs on job work basis in India.
Interactive charts & full statements → Open the GUJTHEM valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹1.7B | ₹1.7B | ₹1.5B | ₹1.7B | ₹1.5B | — |
| Gross Profit | ₹1.5B | ₹1.4B | ₹1.2B | ₹1.3B | ₹1.2B | — |
| Operating Income (EBIT) | ₹675M | ₹648M | ₹642M | ₹756M | ₹725M | — |
| Net Income | ₹487M | ₹467M | ₹488M | ₹592M | ₹580M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹438M | ₹442M | ₹434M | ₹424M | ₹359M | — |
| Gross Profit | ₹384M | ₹393M | ₹361M | ₹349M | ₹279M | — |
| Operating Income (EBIT) | ₹168M | ₹153M | ₹174M | ₹180M | ₹119M | — |
| Net Income | ₹111M | ₹109M | ₹125M | ₹143M | ₹91M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹73M) | (₹18M) | (₹69M) | (₹124M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹5.0B | ₹3.0B | ₹2.2B | ₹1.7B | — |
| Total Liabilities | ₹2.2B | ₹529M | ₹197M | ₹172M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GUJTHEM viewer.
About TickerBase · Data methodology & sources · Privacy · Terms